Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $7,500	278 Pages	The Business Research Company	January, 2025	BRC19511461

Best Price Guarantee
Price	from $7,500
Length	278 Pages
Publisher	The Business Research Company
Published Date	January, 2025
SKU	BRC19511461

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Including: 1) By Type: Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM); Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)2) By Drug: Tafamidis; Patisiran; Inotersen3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc.

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global transthyretin amyloidosis treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest-growing market for transthyretin amyloidosis treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The transthyretin amyloidosis treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider transthyretin amyloidosis treatment market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by drug and by distribution channel.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the transthyretin amyloidosis treatment market.

Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by drug and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for transthyretin amyloidosis treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM); Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)

2) By Drug: Tafamidis; Patisiran; Inotersen; Other Drugs

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; transthyretin amyloidosis treatment indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1 Transthyretin Amyloidosis Treatment – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Transthyretin Amyloidosis Treatment Market Definition And Segmentations; 6.4 Market Segmentation By Type; 6.4.1 Transthyretin Amyloidosis With Polyneuropathy; 6.4.2 Transthyretin Amyloidosis With Cardiomyopathy; 6.5 Market Segmentation By Drug; 6.5.1 Tafamidis; 6.5.2 Patisiran; 6.5.3 Inotersen; 6.5.4 Other Drugs; 6.6 Market Segmentation By Distribution Channel; 6.6.1 Hospital Pharmacies; 6.6.2 Retail Pharmacies; 6.6.3 Online Pharmacies
7 Major Market Trends: 7.1 Advancing Treatment Options For Amyloidosis With Novel Therapeutic Antibody
8 Transthyretin Amyloidosis Treatment Market - Macro Economic Scenario: 8.1 COVID-19 Impact On The Transthyretin Amyloidosis Treatment Market; 8.2 Impact Of The War In Ukraine On The Transthyretin Amyloidosis Treatment Market; 8.3 Impact Of High Inflation On The Transthyretin Amyloidosis Treatment Market
9 Global Market Size and Growth: 9.1 Market Size; 9.2 Historic Market Growth, 2018 – 2023, Value ($ Million); 9.2.1 Market Drivers 2018 – 2023; 9.2.2 Market Restraints 2018 – 2023; 9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million); 9.3.1 Market Drivers 2023 – 2028; 9.3.2 Market Restraints 2023 – 2028
10 Global Transthyretin Amyloidosis Treatment Market Segmentation: 10.1 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.2 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.3 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Transthyretin Amyloidosis Treatment Market, Regional and Country Analysis: 11.1 Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 11.2 Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market: 12.1 Summary; 12.2 Market Overview; 12.2.1 Region Information; 12.2.2 Market Information; 12.2.3 Background Information; 12.2.4 Government Initiatives; 12.2.5 Regulations; 12.2.6 Regulatory Bodies; 12.2.7 Major Associations; 12.2.8 Taxes Levied; 12.2.9 Corporate Tax Structure; 12.2.10 Investments; 12.2.11 Major Companies; 12.3 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.4 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.5 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.6 China Market; 12.7 Summary; 12.8 Market Overview; 12.8.1 Country Information; 12.8.2 Market Information; 12.8.3 Background Information; 12.8.4 Government Initiatives; 12.8.5 Regulations; 12.8.6 Regulatory Bodies; 12.8.7 Major Associations; 12.8.8 Taxes Levied; 12.8.9 Corporate Tax Structure; 12.8.10 Major Companies; 12.9 China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.10 China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.11 China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.12 India Market; 12.13 India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.14 India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.15 India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.16 Japan Market; 12.17 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.18 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.19 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.20 Australia Market; 12.21 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.22 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.23 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.24 Indonesia Market; 12.25 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.26 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.27 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.28 South Korea Market; 12.29 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.30 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.31 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market: 13.1 Summary; 13.2 Market Overview; 13.2.1 Region Information; 13.2.2 Market Information; 13.2.3 Background Information; 13.2.4 Government Initiatives; 13.2.5 Regulations; 13.2.6 Regulatory Bodies; 13.2.7 Major Associations; 13.2.8 Taxes Levied; 13.2.9 Corporate tax structure; 13.2.10 Investments; 13.2.11 Major Companies; 13.3 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.4 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.5 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.6 Western Europe Transthyretin Amyloidosis Treatment Market: Country Analysis; 13.7 UK Market; 13.8 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.9 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.10 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.11 Germany Market; 13.12 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.13 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.14 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.15 France Market; 13.16 France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.17 France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.18 France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.19 Italy Market; 13.20 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.21 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.22 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.23 Spain Market; 13.24 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.25 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.26 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market: 14.1 Summary; 14.2 Market Overview; 14.2.1 Region Information; 14.2.2 Market Information; 14.2.3 Background Information; 14.2.4 Government Initiatives; 14.2.5 Regulations; 14.2.6 Regulatory Bodies; 14.2.7 Major Associations; 14.2.8 Taxes Levied; 14.2.9 Corporate Tax Structure; 14.2.10 Investments; 14.2.11 Major companies; 14.3 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.4 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.5 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.6 Eastern Europe Transthyretin Amyloidosis Treatment Market: Country Analysis; 14.7 Russia Market; 14.8 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.9 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.10 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market: 15.1 Summary; 15.2 Market Overview; 15.2.1 Region Information; 15.2.2 Market Information; 15.2.3 Background Information; 15.2.4 Government Initiatives; 15.2.5 Regulations; 15.2.6 Regulatory Bodies; 15.2.7 Major Associations; 15.2.8 Taxes Levied; 15.2.9 Corporate Tax Structure; 15.2.10 Investments; 15.2.11 Major Companies; 15.3 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.4 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.5 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.6 North America Transthyretin Amyloidosis Treatment Market: Country Analysis; 15.7 USA Market; 15.8 Summary; 15.9 Market Overview; 15.9.1 Country Information; 15.9.2 Market Information; 15.9.3 Background Information; 15.9.4 Government Initiatives; 15.9.5 Regulations; 15.9.6 Regulatory Bodies; 15.9.7 Major Associations; 15.9.8 Taxes Levied; 15.9.9 Corporate Tax Structure; 15.9.10 Investments; 15.9.11 Major Companies; 15.10 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.11 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.12 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.13 Canada Market; 15.14 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.15 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.16 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market: 16.1 Summary; 16.2 Market Overview; 16.2.1 Region Information; 16.2.2 Market Information; 16.2.3 Background Information; 16.2.4 Government Initiatives; 16.2.5 Regulations; 16.2.6 Regulatory Bodies; 16.2.7 Major Associations; 16.2.8 Taxes Levied; 16.2.9 Corporate Tax Structure; 16.2.10 Investments; 16.2.11 Major Companies; 16.3 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.4 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.5 South America Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.6 South America Transthyretin Amyloidosis Treatment Market: Country Analysis; 16.7 Brazil Market; 16.8 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.9 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.10 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market: 17.1 Summary; 17.2 Market Overview; 17.2.1 Region Information; 17.2.2 Market Information; 17.2.3 Background Information; 17.2.4 Government Initiatives; 17.2.5 Regulations; 17.2.6 Regulatory Bodies; 17.2.7 Major Associations; 17.2.8 Taxes Levied; 17.2.9 Corporate Tax Structure; 17.2.10 Major Companies; 17.3 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 17.4 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 17.5 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market: 18.1 Summary; 18.2 Market Overview; 18.2.1 Region Information; 18.2.2 Market Information; 18.2.3 Background Information; 18.2.4 Government Initiatives; 18.2.5 Regulations; 18.2.6 Regulatory Bodies; 18.2.7 Major Associations; 18.2.8 Taxes Levied; 18.2.9 Major Companies; 18.3 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 18.4 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 18.5 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles: 19.1 Company Profiles; 19.2 Pfizer Inc; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.2.3 Business Strategy; 19.2.4 Financial Overview; 19.3 Alnylam Pharmaceuticals, Inc; 19.3.1 Company Overview; 19.3.2 Products And Services; 19.3.3 Business Strategy; 19.3.4 Financial Overview; 19.4 Ionis Pharmaceuticals, Inc; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.4.3 Business Strategy; 19.4.4 Financial Overview; 19.5 BridgeBio Pharma, Inc; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.5.3 Business Strategy; 19.6 Intellia Therapeutics Inc; 19.6.1 Company Overview; 19.6.2 Products And Services; 19.6.3 Business Strategy
20 Other Major And Innovative Companies: 20.1 AstraZeneca; 20.1.1 Company Overview; 20.1.2 Products And Services; 20.2 Novo Nordisk A/S; 20.2.1 Company Overview; 20.2.2 Products And Services; 20.3 PTC Therapeutics Inc.; 20.3.1 Company Overview; 20.3.2 Products And Services; 20.4 Bristol-Myers Squibb Company; 20.4.1 Company Overview; 20.4.2 Products And Services; 20.5 Abbvie Inc.; 20.5.1 Company Overview; 20.5.2 Products And Services; 20.6 SOM Biotech; 20.6.1 Company Overview; 20.6.2 Products And Services; 20.7 Corino Therapeutics Inc.; 20.7.1 Company Overview; 20.7.2 1.7.2 Products And Services; 20.8 Acrotech Biopharma Inc.; 20.8.1 Company Overview; 20.8.2 Products And Services; 20.9 Neurimmune AG; 20.9.1 Company Overview; 20.9.2 Products And Services; 20.10 Sorrento Therapeutics, Inc.; 20.10.1 Company Overview; 20.10.2 Products And Services; 20.11 Oncopeptides AB; 20.11.1 Company Overview; 20.11.2 Products And Services; 20.12 Takeda Pharmaceutical Company Limited; 20.12.1 Company Overview; 20.12.2 Products And Services; 20.13 Astellas Pharma, Inc.; 20.13.1 Company Overview; 20.13.2 Products And Services; 20.14 GSK plc; 20.14.1 Company Overview; 20.14.2 Products And Services; 20.15 Bausch Health Company; 20.15.1 Company Overview; 20.15.2 Products And Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions: 23.1 Astellas Pharma Acquired Polyphor International; 23.2 AstraZeneca Acquired Caelum Biosciences; 23.3 Novo Nordisk Acquired Prothena Corporation
24 Opportunities And Strategies: 24.1 Global Transthyretin Amyloidosis Treatment Market In 2028 – Countries Offering Most New Opportunities; 24.2 Global Transthyretin Amyloidosis Treatment Market In 2028 – Segments Offering Most New Opportunities; 24.3 Global Transthyretin Amyloidosis Treatment Market In 2028 – Growth Strategies; 24.3.1 Market Trend Based Strategies; 24.3.2 Competitor Strategies
25 Transthyretin Amyloidosis Treatment Market, Conclusions And Recommendations: 25.1 Conclusions; 25.2 Recommendations; 25.2.1 Product; 25.2.2 Place; 25.2.3 Price; 25.2.4 Promotion; 25.2.5 People
26 Appendix: 26.1 Geographies Covered; 26.2 Market Data Sources; 26.3 Research Methodology; 26.4 Currencies; 26.5 The Business Research Company; 26.6 Copyright and Disclaimer